0.1%: If the following adverse reactions are observed, appropriate measures such as discontinuing should be taken. (See table).
Click on icon to see table/diagram/image
0.3%: If ophthalmic or hypersensitivity symptoms are observed such as itching, irritation, conjunctivitis, conjunctival injection, corneal lesion such as keratitis superfacialis diffusa, foreign body sensation, blepharitis, and eyelid dermatitis, appropriate measures such as discontinuing administration should be taken.
If the patient notices any side effect that is not listed previously, please inform the doctor or pharmacist.